Skip to main content
OpenTrials

Clinical trial condition

Protoporphyria, Erythropoietic

Explore clinical trials studying Protoporphyria, Erythropoietic. Study availability and eligibility vary by location and protocol.

22 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Protoporphyria, Erythropoietic trial results

Recruiting

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

NCT07567131

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +11 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Mount Sinai School of Medicine New York, United States
  • Wake Forest University Baptist Health - Dept of Gastroenterology Wake Forest, North Carolina, United States
  • Temple University Philadelphia, Pennsylvania, United States
View all 19 locations
View Trial Details
Enrolling by Invitation

HELIOS: Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants With EPP or XLP

NCT05883748

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Completed

Effect of Oral Cimetidine in the Protoporphyrias

NCT05020184

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +13 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Atrium Health Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States
  • University of Texas Medical Branch Galveston, Texas, United States
View Trial Details
Completed

INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP

NCT06144840

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +12 more
Locations
  • Marvel Clinical Research, LLC Huntington Beach, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University Of Miami School Of Medicine, Center For Liver Diseases Miami, Florida, United States
  • MGH Boston, Massachusetts, United States
View all 35 locations
View Trial Details
Completed

Study of Bitopertin to Evaluate the Safety, Tolerability, Efficacy, and PPIX Concentrations in Participants With EPP

NCT05308472

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • University of Alabama Hospital Birmingham, Alabama, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria

NCT03520036

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria (EPP), +10 more
Locations
  • ACTCA, A Member of the Alliance, Inc. Los Angeles, California, United States
  • University of California at San Francisco San Francisco, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Metro Boston Clinical Partners, LLC Brighton, Massachusetts, United States
View Trial Details
Completed

Phase III Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT00979745

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Erythropoietic Protoporphyria, +10 more
Locations
  • HUS:n Iho-ja allergiasairaala (Skin and Allergy Hospital) Helsinki, Finland
  • Centre Français des Porphyries, Hôpital Louis Mourier Colombes, Cedex, France
  • Department of Dermatology , Heinrich-Heine-University Duesseldorf Düsseldorf, Germany
  • Beaumont Hospital, Department of Dermatology Dublin, Ireland
View Trial Details

Related conditions